Evidence map›Paper›PMID 40430454›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Electrospun Nanofiber-Scaffold-Loaded Levocetirizine Dihydrochloride Cerosomes for Combined Management of Atopic Dermatitis and Methicillin-Resistant

Rofida Albash, Samer Khalid Ali, Rehab Abdelmonem, Ahmed M Agiba, Renad Aldhahri, Asmaa Saleh, Amira B Kassem, Menna M Abdellatif

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rofida AlbashDepartment of Pharmaceutics, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza 12585, Egypt.
Samer Khalid AliCollege of Pharmacy, Al-Ayen Iraqi University, Nasiriyah 64001, Iraq.ORCID 0000-0003-2493-2825
Rehab AbdelmonemDepartment of Industrial Pharmacy, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza 12566, Egypt.ORCID 0000-0002-2522-8082
Ahmed M AgibaSchool of Engineering and Sciences, Tecnologico de Monterrey, Monterrey 64849, Mexico.ORCID 0000-0003-3635-9093
Renad AldhahriDepartment of Pharmaceutical Care, King Abdullah bin Abdulaziz University Hospital, Riyadh 13412, Saudi Arabia.
Asmaa SalehDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.ORCID 0000-0002-6286-319X
Amira B KassemClinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Damanhour University, Damanhour 22514, Egypt.
Menna M AbdellatifDepartment of Industrial Pharmacy, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza 12566, Egypt.ORCID 0000-0001-9024-1972

Funding

Princess Nourah bint Abdulrahman University Researchers PNURSP2025R141
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

atomic force microscopyatopic dermatitiscerosomesconfocal laser scanning microscopylevocetirizine dihydrochlorideMRSA skin infectionnanofiber

Identifiers

PMID40430454
PMCPMC12114773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.